Patents by Inventor Lawrence J. Burgart

Lawrence J. Burgart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110217731
    Abstract: A pathology sample processing workstation. The samples are positioned on containers having RFID tags and processed at stations having RFID transceivers coupled to a computer. Information regarding the samples can stored on the RFID tags and retrieved using the transceivers.
    Type: Application
    Filed: May 18, 2011
    Publication date: September 8, 2011
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Lawrence J. BURGART, Schuyler O. SANDERSON
  • Publication number: 20090029365
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with colon cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human colon cancers are provided.
    Type: Application
    Filed: March 21, 2008
    Publication date: January 29, 2009
    Inventors: Allison Berger, Tracy L. Guillemette, Robert Schlegel, John E. Monahan, Shubhangi Kamatkar, Stephen N. Thibodeau, Lawrence J. Burgart
  • Publication number: 20080305515
    Abstract: A pathology sample processing workstation. The samples are positioned on containers having RFID tags and processed at stations having RFID transceivers coupled to a computer. Information regarding the samples can stored on the RFID tags and retrieved using the transceivers.
    Type: Application
    Filed: August 9, 2006
    Publication date: December 11, 2008
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Lawrence J. Burgart, Schuyler O. Sanderson
  • Publication number: 20080194043
    Abstract: The present invention relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1? or TIMP1 nucleic acid or amino acid molecules in a clinical sample obtained from the patient, wherein Reg1? or TIMP1 expression is indicative of the presence of colorectal cancer. The invention further relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1? or TIMP1 nucleic acid or amino acid molecules in a clinical sample, in addition to detecting the presence of one or more additional colorectal cancer associated markers.
    Type: Application
    Filed: March 21, 2008
    Publication date: August 14, 2008
    Inventors: Jon H. ASTLE, Christopher C. BURGESS, Theodore J. CATINO, Poornima DWIVEDI, Maryanne HUNTRESS, Karen Anne JOHNSON, Marcia E. LEWIS, Peter J. MAIMONIS, Gary A. MOLINO, Susan H. MYEROW, Arunthathi THIAGALINGAM, Lisa Allyn BOARDMAN, Lawrence J. BURGART, Stephen N. THIBODEAU, Sheryl BROWN-SHIMER
  • Patent number: 7258973
    Abstract: This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: August 21, 2007
    Assignees: Mayo Foundation for Medical Education & Research, Bayer Healthcare, LLC
    Inventors: Jon H. Astle, Christopher C. Burgess, Theodore J. Catino, Poornima Dwivedi, Marcia E. Lewis, Gary A. Molino, Susan H. Myerow, Arunthathi Thiagalingam, Stephen Thibodeau, Lawrence J. Burgart, Lisa Allyn Boardman
  • Patent number: 7211398
    Abstract: This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.
    Type: Grant
    Filed: October 25, 2002
    Date of Patent: May 1, 2007
    Assignees: Bayer Corporation, Mayo Foundation for Medical Education and Research
    Inventors: Jon H. Astle, Christopher C. Burgess, Theodore J. Catino, Poornima Dwivedi, Marcia E. Lewis, Gary A. Molino, Susan H. Myerow, Arunthathi Thiagalingam, Stephen Thibodeau, Lawrence J. Burgart, Lisa Allyn Boardman
  • Publication number: 20040157278
    Abstract: The present invention relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1&agr; or TIMP1 nucleic acid or amino acid molecules in a clinical sample obtained from the patient, wherein Reg1&agr; or TIMP1 expression is indicative of the presence of colorectal cancer. The invention further relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1&agr; or TIMP1 nucleic acid or amino acid molecules in a clinical sample, in addition to detecting the presence of one or more additional colorectal cancer associated markers.
    Type: Application
    Filed: December 12, 2003
    Publication date: August 12, 2004
    Applicants: Bayer Corporation, Mayo Foundation for Medical Education & Research
    Inventors: Jon H. Astle, Christopher C. Burgess, Theodore J. Catino, Poornima Dwivedi, Maryanne Huntress, Karen Anne Johnson, Marcia E. Lewis, Peter J. Maimonis, Gary A. Molino, Susan H. Myerow, Arunthathi Thiagalingam, Lisa Allyn Boardman, Lawrence J. Burgart, Stephen N. Thibodeau, Sheryl Brown-Shimer
  • Publication number: 20040146879
    Abstract: This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.
    Type: Application
    Filed: June 30, 2003
    Publication date: July 29, 2004
    Applicants: Bayer HealthCare LLC, Mayo Foundation for Medical Education & Research
    Inventors: Jon H. Astle, Lisa Allyn Boardman, Lawrence J. Burgart, Christopher C. Burgess, Theodore J. Catino, Poornima Dwivedi, Marcia E. Lewis, Gary A. Molino, Susan H. Myerow, Arunthathi Thiagalingam, Stephen N. Thibodeau
  • Publication number: 20030148410
    Abstract: The invention relates to newly discovered nucleic acid molecules and proteins associated with colon cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human colon cancers are provided.
    Type: Application
    Filed: November 21, 2002
    Publication date: August 7, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Allison Berger, Tracy L. Guillemette, Robert Schlegel, John E. Monahan, Shubhangi Kamatkar, Stephen N. Thibodeau, Lawrence J. Burgart